Viewing nowCandesartan Tablets 16 mg (Candesartan Cilexetil)
Candesartan Cilexetil 16mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

MFDS item code 201906420 · Approved 2019.09.11 · Insurance code 694002620
Treatment of essential hypertension and heart failure with reduced left ventricular systolic function
This medication is primarily used to treat essential hypertension. It is also used as an add-on therapy when mono therapy with ACE inhibitors is inadequate or poorly tolerated in patients with heart failure and impaired left ventricular systolic function. Through these effects, it helps stabilize blood pressure and manage symptoms of heart failure.
This drug should be taken at the same time each day, with or without food. 1. Essential hypertension Adults: The recommended initial and maintenance dose is 8 ∼ 16 mg of candesartan cilexetil, administered orally once daily. If blood pressure is not adequately controlled after 4 weeks of treatment with 16 mg once daily, the dose may be increased to a maximum of 32 mg once daily. If blood pressure is still not controlled at this dose, other treatments should be considered. The maximum effect is achieved within 4 weeks after starting treatment. Elderly patients: No adjustment of the initial dose is necessary. Patients with intravascular volume depletion: For patients at increased risk of hypotension, such as those with volume depletion, administer an initial dose of 4 mg with careful attention. Patients with renal impairment: The initial dose for patients with renal impairment, including those receiving hemodialysis, is 4 mg; adjust the dose according to the patient's response. Experience in patients with severe or end-stage renal impairment (creatinine clearance < 15 mL/min) is limited. Patients with hepatic impairment: The initial dose for patients with mild to moderate hepatic impairment is 2 mg once daily; adjust the dose according to the patient's response. There is no experience in patients with severe hepatic impairment. 2. Heart failure Adults: An initial dose of 4 mg once daily is recommended. The dose may be doubled at intervals of at least 2 weeks and increased up to a maximum of 32 mg once daily, taking the patient's tolerability into account. Elderly patients, patients with intravascular volume depletion, patients with renal impairment, and patients with mild to moderate hepatic impairment: No adjustment of the initial dose is necessary.
1. Essential hypertension Adolescents and children aged 18 years or younger: Safety and efficacy have not been established. 2. Heart failure Adolescents and children aged 18 years or younger: Safety and efficacy have not been established.
This medication can cause serious harm to the fetus, especially during the second and third trimesters of pregnancy, so it should be discontinued immediately if pregnancy is confirmed. The medication should not be used in patients with known allergies to it or its components, pregnant or nursing women, patients with severe hepatic impairment or cholestasis, and patients with hereditary angioedema. Elderly patients, those with renal impairment, hyperkalemia, hepatic impairment, valvular heart disease, or renal artery stenosis should use this medication with caution. Side effects such as dizziness, back pain, respiratory infections, and others may occur, and rarely serious blood abnormalities, liver dysfunction, myalgia, or renal impairment may occur. Particularly in heart failure patients, side effects such as hypotension, hyperkalemia, and renal function impairment may occur, thus regular blood tests and monitoring are necessary. This medication may significantly lower blood pressure; if symptoms of sudden drops in blood pressure, fainting, or loss of consciousness occur, immediate consultation with healthcare professionals is required. When used with other antihypertensive medications or diuretics, caution is needed due to increased risk of side effects from interactions. Pregnant women or those planning to become pregnant should not take this medication, and nursing women are also advised to avoid it. Safety in children or adolescents under 18 years of age has not been established, and use is not recommended. Patients should be cautious when driving or operating machinery as dizziness or drowsiness may occur during treatment. In cases of overdose, symptoms such as hypotension, dizziness, and tachycardia may manifest, and emergency treatment should be sought immediately. This medication should be kept out of the reach of children and should not be transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture and is best kept at room temperature between 1°C and 30°C. This storage maintains the effectiveness and safety of the medication.
Light pink-yellow tablets, round with a convex shape on both sides.
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCandesartan Cilexetil 16mg
Tablet · Prescription medication
Daewoong Bio Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Yuhans Chemical Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Yuhan Corporation

Candesartan Cilexetil 32mg
Tablet · Prescription medication
DKSH Korea Co., Ltd.

Candesartan Cilexetil 8mg
Tablet · Prescription medication
Jong Kun Dang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
Ajou Pharmaceutical Co., Ltd.

Candesartan Cilexetil 16mg
Tablet · Prescription medication
ShinPoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.